Daniel L. Reuvers

2018

In 2018, Daniel L. Reuvers earned a total compensation of $1.8M as Corporate Vice President, President, Codman Surgical Solutions at Integra LifeSciences Holdings, a 43% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$326,000
Option Awards$168,011
Salary$418,920
Stock Awards$892,085
Other$13,363
Total$1,818,379

Reuvers received $892.1K in stock awards, accounting for 49% of the total pay in 2018.

Reuvers also received $326K in non-equity incentive plan, $168K in option awards, $418.9K in salary and $13.4K in other compensation.

Rankings

In 2018, Daniel L. Reuvers' compensation ranked 6,213th out of 14,244 executives tracked by ExecPay. In other words, Reuvers earned more than 56.4% of executives.

ClassificationRankingPercentile
All
6,213
out of 14,244
56th
Division
Manufacturing
2,377
out of 5,758
59th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
302
out of 849
64th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
169
out of 547
69th
Industry
Surgical and Medical Instruments and Apparatus
104
out of 348
70th

Pay ratio

Daniel L. Reuvers' Pay$1,818,379
Median Employee's Pay$73,170
Pay Ratio

25

to 1

In 2018, the annual total compensation of Daniel L. Reuvers was $1,818,379.

The annual total compensation of the median employee at Integra LifeSciences Holdings was $73,170.

The ratio of Daniel L. Reuvers' pay to the pay of median employee was therefore 25 to one.

Source: SEC filing on April 16, 2019.

Reuvers' colleagues

We found five more compensation records of executives who worked with Daniel L. Reuvers at Integra LifeSciences Holdings in 2018.

2018

Peter Arduini

Integra LifeSciences Holdings

Chief Executive Officer

2018

Richard Gorelick

Integra LifeSciences Holdings

General Counsel

2018

Glenn Coleman

Integra LifeSciences Holdings

Chief Financial Officer

2018

Robert Davis

Integra LifeSciences Holdings

Corporate Vice President, President, Orthopedics and Tissue Technologies

2018

Eric Schwartz

Integra LifeSciences Holdings

General Counsel

News

You may also like